
Quantum Innovations sp. z o.o.
Research and experimental development on biotechnology
Overview
Quantum Innovations creates technologies for cardiac surgery, cardiology and respiratory medicine. Its products include the Heart Sense probe, designed to increase safety during cardiac surgery, and Heart Guard, a system for continuous measurement of cardiac metabolism; the devices aim to improve the safety of invasive procedures in cardiac surgery centers.
Financials
Revenue history (in k)
Filing timeliness
1 of 6 financial statements was filed late (for 2021, 32 days late). 2 of 6 audited by a statutory auditor.
- 202524/06/2026
- 202426/06/2025
- 202318/04/2024
- 202209/06/2023
- 202116/08/2022
- 202016/07/2021
Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.
Statistics
How the company ranks by revenue within its industry, city, voivodeship and across Poland in 2025.
Results vs industry
Industry
Offer
- Research on cardiac technologies
- Cardiac surgery probe
- Cardiac metabolism measurement system
Websites
- quantuminnovations.plQuantum InnovationsCloudflare
Trademarks
The company holds 1 active trademark registered with the Polish Patent Office. The first mark was filed in 2024.
| Mark | Number | Classes | Status | Protected until | |
|---|---|---|---|---|---|
| QUANTUM INNOVATIONS (word) | Z.577031 | 9, 10, 41, 42, 44 | Protected | Nov 20, 2034 |
| Mark | Protected until | |
|---|---|---|
| QUANTUM INNOVATIONS (word) | Nov 20, 2034 |
Authorized Representatives
Manner of representation
Declarations of will on behalf of the company require the joint action of two members of the management board or one member of the management board and a commercial proxy. If a member of the management board representing the investor is appointed, declarations of will on behalf of the company require the joint action of the member of the management board–the Finance Director–with another member of the management board or a commercial proxy.
Supervisory board
Ownership
| Owner | Shares | Share value | Stake |
|---|---|---|---|
Przemysław Robert Furdal age 38 | 64 | $864.40 | 22.5352% |
| 64 | $864.40 | 22.5352% | |
Grzegorz Łukasz Suwalski age 47 | 78 | $1,053.48 | 27.4648% |
| 78 | $1,053.48 | 27.4648% |
Beneficial owners
| Person | Rights |
|---|---|
Sanctions and PEP
Sanctions
No matches (EU, UN, US, UK, MSWiA, World Bank)
PEP
No matches
Bank accounts
Registered as a VAT taxpayer on 2017-08-10.
04 1090 1883 0000 0001 3409 0096
Debt
No entries in the National Debtors Register (KRZ).
Public aid
| Grant date | Purpose | Gross amount | Granting body | |
|---|---|---|---|---|
| Jan 22, 2019 | De minimis aid (in accordance with Commission Regulation No 1407/2013 or earlier) | $8,008$8,008 | Fundacja Innowacyjna Polska | |
| Jan 14, 2019 | De minimis aid (in accordance with Commission Regulation No 1407/2013 or earlier) | $2,883$2,883 | BTM Innovations sp. z o.o. | |
| Jun 7, 2018 | De minimis aid (in accordance with Commission Regulation No 1407/2013 or earlier) | $5,787$5,787 | BTM Innovations sp. z o.o. |
Regulatory authorisations
| Authority | Type | Status | |
|---|---|---|---|
| BDO register entry | Active |
Competitors
| Name | Revenue | Website | ||
|---|---|---|---|---|
| Orthoget S.A. | $532,980.53 | orthoget.com | ||
| Aidmed sp. z o.o. | $263,700.89 | aidmed.ai | ||
| F.R.K. Intra-Cordis sp. z o.o. | $215,043.19 | intracordis.com.pl | ||
| AUG Medical sp. z o.o. | $141,688.75 | augmedical.pl | ||
| Accrea Engineering sp. z o.o. | $134,070.43 | accrea.com | ||
| Hagmed sp. z o.o. | $94,318.82 | hagmed.com | ||
| Spark Group sp. z o.o. | $75,379.54 | sparkgroup.com.pl | ||
| Medinice B+R sp. z o.o. | $43,773.58 | medinice.pl | ||
| OPTI G sp. z o.o. | $34,289.31 | optig.pl | ||
| Simplicardiac S.A. | $28,951.71 | simplicardiac.com |
Change history
| Date | Event | |
|---|---|---|
| 2025-11-13 | Address change (Ul. Młynarska 8/12, 01-194, Warszawa → Plac Bankowy 2, 00-095, Warszawa) | |
| 2024-10-01 | Share capital increase (11,200.00 PLN → 14,200.00 PLN) | |
| 2024-08-21 | Address change (Ul. Sarmacka 11/114, 02-972, Warszawa → Ul. Młynarska 8/12, 01-194, Warszawa) | |
| 2024-06-25 | Share capital increase (5,000.00 PLN → 11,200.00 PLN) | |
| 2021-06-25 | Address change (Ul. Józefa I Jana Rostafińskich 4, 02-593, Warszawa → Ul. Sarmacka 11/114, 02-972, Warszawa) |
FAQ
Last updated: 2026-06-24